Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Denmark
/
Healthcare
/
NNIT
NNIT
NNIT
Global Uncertainty Will Delay IT Projects Yet Spur Renewal
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
24 Aug 25
Updated
24 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
DKK 70.00
11.6% undervalued
intrinsic discount
24 Aug
DKK 61.90
1Y
-39.2%
7D
-3.4%
Loading
1Y
-39.2%
7D
-3.4%
Author's Valuation
DKK 70.0
11.6% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
DKK 70.0
11.6% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-304m
3b
2014
2017
2020
2023
2025
2026
2028
Revenue DKK 2.3b
Earnings DKK 238.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.51%
Healthtech revenue growth rate
4.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.43%
Calculation
DKK 238.45m
Earnings '28
x
8.50x
PE Ratio '28
=
DKK 2.03b
Market Cap '28
DKK 2.03b
Market Cap '28
/
24.89m
No. shares '28
=
DKK 81.37
Share Price '28
DKK 81.37
Share Price '28
Discounted to 2025 @ 6.44% p.a.
=
DKK 67.49
Fair Value '25
